MALDI-MSI and label-free LC-ESI-MS/MS shotgun proteomics to investigate protein induction in a murine fibrosarcoma model following treatment with a vascular disrupting agent

Proteomics

Volumn 14, Issue 7-8, 2014, Pages 890-903

  Cole, Laura M ^a   Bluff, Joanne E ^b   Carolan, Vikki A ^a   Paley, Martyn N ^b   Tozer, Gillian M ^b   Clench, Malcolm R ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Biomedicine; CA4P; HSP 90; Plectin; Stress induced molecular chaperones; Vascular disrupting agents

Indexed keywords

ACTIN; ALPHA 2 MACROGLOBULIN; ALPHA ACTIN; ALPHA ACTIN 1; BETA ACTIN; CHAPERONE; COMBRETASTATIN A4 PHOSPHATE; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN 90; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; HISTONE H2A; HISTONE H3; PLECTIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; CELL DEATH; CELL STRUCTURE; CELL SURVIVAL; COMPUTER PROGRAM; DNA DAMAGE; ELECTROSPRAY MASS SPECTROMETRY; FIBROSARCOMA; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TUMOR CELL; TUMOR VASCULARIZATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MASS SPECTROMETRY; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PROCEDURES;

ANIMALS; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN INTERACTION MAPS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STILBENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84897413741     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300429     Document Type: Article

References (36)

1. Tozer, G. M., Akerman, S., Cross, N. A., Barber, P. R. et al., Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumours. Cancer Res. 2008, 68, 2301-2311.
2. Cole, L. M., Djidja, M.-C., Bluff, J. E., Claude, E. et al., Investigation of protein induction in tumour vascular targeted strategies by MALDI MSI. Methods. 2011, 54, 442-453.
3. Schwartz, S. A., Wei, l. R. J., Johnson, M. D., Toms, S. A., Caprioli, R. M., Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Cli. Cancer Res. 2004, 10, 981-987.
4. Chaurand, P., DaGue, B. B., Pearsall, R. S., Threadgill, D. W., Caprioli, R. M., Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics 2001, 1, 1320-1326.
5. Lemaire, R., Desmons, A., Tabet, J. C., Day, R. et al., Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J. Proteome Res. 2007, 6, 1295-1305.
6. Schwamborn, K., Krieg, R. C., Reska, M., Jakse, G. et al., Identifying prostate carcinoma by MALDI-Imaging. Int. J. Mol. Med. 2007, 20, 155-159.
7. Lemaire, R., Menguellet, S. A., Stauber, J., Marchaudon, V. et al., Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteosome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. J. Proteome Res. 2007, 6, 4127-4134.
8. Shimma, S., Furuta, M., Ichimura, K., Yoshida, Y., Setou, M., A novel approach to in situ proteome analysis using inkjet printing technology and MALDI-QIT-TOF tandem mass spectrometer. J. Mass Spectrom. Soc. Jpn. 2006, 54, 133-140.
9. Groseclose, M. R., Andersson, M., Hardesty, W. M., Caprioli, R. M., Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. J. Mass Spectrom. 2007, 42, 254-262.
10. Workman, P., Aboagye, E. O., Balkwill, F., Balmain, A. et al., and An ad hoc committee of the National Cancer Research Institute, Br. J. Cancer. 2010, 102, 1555-1577.
11. Kline, K. G., Wu, C. C., MudPIT analysis: application to human heart tissue. Methods Mol. Biol. 2009, 528, 281-293.
12. Kanthou, C., Tozer, G. M., The tumour vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells. Blood 2002, 99, 2060-2069.
13. Wang, Z., Yang, D., Zhang, X., Li, T. et al., Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS ONE 2011, 6, e19229.
14. Neckers, L., Heat shock protein 90: the cancer chaperone. J. Biosci. 2007, 32, 517-530.
15. Den, R. B., Lu, B., Heat shock protein 90 inhibition: rationale and clinical potential. Ther. Adv. Med. Oncol. 2012, 4, 211-218.
16. Jameel, A., Skilton, R. A., Campbell, T. A., Chander, S. K. et al., Clinical and biological significance of HSP89 alpha in human breast cancer. Int. J. Cancer 1992, 50, 409-415.
17. Welford, A. F., Biziato, D., Coffelt, S. B., Nucera, S. et al., TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin a4 phosphate in mice. J. Clin. Invest. 2011, 121, 1-5.
18. Feige, J. J., Negoescu, A., Keramidas, M., Souchelnitskiy, S., Chambaz, E. M., Alpha 2-macroglobulin: a binding protein for transforming growth factor-beta and various cytokines. Hormone Res. 1996, 45, 227-232.
19. Ey, L., Li, J. F., Gnatovskiy, L., Deng, Y. et al., Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006, 66, 11238-11246.
20. Bingle, L., Brown, N. J., Lewis, C. E., The role of tumour associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 2002, 196, 254-265.
21. Katada, K., Tomonagab, T., Satoh, M., Matsushita, K. et al., Plectin promotes migration and invasion of cancer cells and is a novel prognostic marker for head and neck squamous cell carcinoma. J. Proteomics 2012, 75, 1803-1815.
22. Winter, L., Wiche, G., The many faces of plectin and plectinopathies: pathology and mechanisms. Acta Neuropathol. 2013, 125, 77-93.
23. Nagle, R. B., Hao, J., Knox, J. D., Dalkin, B. L. et al., Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am. J. Pathol. 1995, 146, 1498-1507.
24. Lee, K. Y., Liu, Y. H., Ho, C. C., Pei, R. J. et al., An early evaluation of malignant tendency with plectin expression in human colorectal adenoma and adenocarcinoma. J. Med. 2004, 35, 141-149.
25. Malarkannan, S., Awasth, A., Rajasekaran, K., Kumar, P. et al., IQGAP1: A regulator of intracellular spacetime relativity. J. Immunol. 2012, 188, 2057-2063.
26. Mataraza, J. M., Briggs, M. W., Zhigang, L., Entwistle, A. et al., IQGAP1 Promotes Cell Motility and Invasion. J. Biol. Chem. 2003, 278, 41237-41245.
27. Oskarsson, T., Acharyya, S., Zhang, X. H.-F., Vanharanta, S. et al., Breast cancer cells produce Tenascin C as a metastaic niche component to colonize lungs. Nat. Med. 2011, 17, 867-874.
28. Brellier, F., Martina, E., Degen, M., Heuzé-Vourc'h, N. et al., Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumours. BMC Clin. Pathol. 2012, 12, 1-10.
29. Pancholi, V., Multifunctional-enolase: its role in diseases. Cell. Mol. Life Sci. 2001, 58, 902-920.
30. Kang, H. J., Jung, S. -K., Kim, S. J., Chung, S. J., Structure of human a-enolase (hENO1), a multifunctional glycolytic enzyme. Acta Crystallogr. Sect. D 2008, D64, 651-657.
31. Sedoris, K. C., Thomas, S. D., Miller, D. M., Hypoxia induces differential translation of enolase/MBP-1. BMC Cancer 2010, 10, 1-14.
32. Capello, M., Ferri-Borgogno, S., Cappello, P., Novellia, F., α-enolase: a promising therapeutic and diagnostic tumor target. FEBS J. 2011, 278, 1064-1074.
33. Li, B., Wen, G., Zhao, Y., Tong, J., Hei, T. K., The role of TGFBI in mesothelioma and breast cancer: association with tumor suppression. BMC Cancer 2012, 12, 1-12.
34. Wiche, G., Role of plectin in cytoskeleton organization and dynamics. J. Cell Sci. 1998, 111, 2477-2486.
35. Zhao, Y., Shao, G., Piao, C. Q., Berenguer, J., Hei, T. K., Down-regulation of Betaig-h3 gene is involved in the tumorigenesis in human bronchial epithelial cells induced by heavy-ion radiation. Radiat. Res. 2004, 162, 655-659.
36. Gilbertson, R. J., Graham, T. A., Cancer: resolving the stem-cell debate. Nature 2012, 488, 462-463.